(R) -MRT199665
(R) -MRT199665 is an isomer of MRT199665. MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells. MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370[1][2][3].
Product Specifications
UNSPSC
12352005
Target
AMPK; Apoptosis; MARK; Salt-inducible Kinase (SIK)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/r-mrt199665.html
Purity
98.70
Smiles
O=C1C(C)(C)C2=CN=C(NC3=CC=CC(CN4CCCC4)=C3)N=C2N1[C@@H]5CCC6=C5C=CC=C6O
Molecular Formula
C28H31N5O2
Molecular Weight
469.58
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Anti-Mouse CD8 (Lyt 2.1) Monoclonal antibody, clone 116-13.1 (HB129)
Mouse Anti-Mouse CD8 (Lyt 2.1) Monoclonal antibody, clone 116-13.1 (HB129)
Mouse Anti-Mouse CD8 (Lyt 2.1) Monoclonal antibody, clone 116-13.1 (HB129)
